MEKK1 activation of human estrogen receptor α and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells

Molecular Endocrinology

Volumn 14, Issue 11, 2000, Pages 1882-1896

  Lee, H ^a   Jiang, F ^a   Wang, Q ^a   Nicosia, S V ^a   Yang, J ^a   Su, B ^a   Bai, W ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; DRUG MECHANISM; ENDOMETRIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

EID: 0033651439     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.11.0554     Document Type: Article

References (42)

1. The steroid and thyroid hormone receptor superfamily
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
4. ER β: Identification and characterization of a novel human estrogen receptor
5. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β
6. The human estrogen receptor has two independent nonacidic transcriptional activation domains
7. Human estrogen receptor transactivation capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
8. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β
9. Expression of estrogen receptor beta (ER β) in multiple rat tissues visualized by immunohistochemistry
10. Phosphorylation and steroid hormone action
11. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor
12. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen
13. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
14. Stimulation of progesterone receptors by phorbol ester and cyclic AMP in fetal uterine cells in culture
15. Antiestrogens antagonize the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture
16. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
17. Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
18. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
19. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
20. Establishment of eighteen clones of Ishikawa cells
21. Proteasome-dependent degradation of the human estrogen receptor
22. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
23. Role of MEKK1 in cell survival and activation of JNK1 and ERK pathways by targeted gene disruption
24. Differential activation of PR-A and PR-B by MEKKs
25. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor
26. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer
27. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1
28. Activation of the JNK pathways is essential for transformation by the Met oncogene
29. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
30. Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor
31. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone
32. Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase
33. Membrane target of nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway
34. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
35. Differential activation of ERK and JNK mitogen activated protein kinases by Ras-1 and MEKK
36. Synergistic interaction of MEKK2, JNKK2, JNK1 results in efficient, specific JNK1 activation
37. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPase Rac and Cdc42Hs
38. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation
39. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension
40. Phosphorylation of human estrogen receptor
41. 211 in the chicken progesterone receptor modulates its transcriptional activity
42. A Simple phase-extraction assay for chloramphenicol acetyltransferase activity